No evidence for pathogenic variants or maternal effect of ZFP57 as the cause of Beckwith-Wiedemann Syndrome.

Center for Applied Human Molecular Genetics, The Kennedy Center, Glostrup, Denmark.
European journal of human genetics: EJHG (Impact Factor: 3.56). 08/2011; 20(1):119-21. DOI: 10.1038/ejhg.2011.140
Source: PubMed

ABSTRACT Beckwith-Wiedemann syndrome (BWS) is an overgrowth syndrome, which, in 50-60% of sporadic cases, is caused by hypomethylation of KCNQ1OT1 differentially methylated region (DMR) at chromosome 11p15.5. The underlying defect of this hypomethylation is largely unknown. Recently, recessive mutations of the ZFP57 gene were reported in patients with transient neonatal diabetes mellitus type 1, showing hypomethylation at multiple imprinted loci, including KCNQ1OT1 DMR in some. The aim of our study was to determine whether ZFP57 alterations were a genetic cause of the hypomethylation at KCNQ1OT1 DMR in patients with BWS. We sequenced ZFP57 in 27 BWS probands and in 23 available mothers to test for a maternal effect. We identified three novel, presumably benign sequence variants in ZFP57; thus, we found no evidence for ZFP57 alterations as a major cause in sporadic BWS cases.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Genomic imprinting is the parent-of-origin specific allelic transcriptional silencing observed in mammals, which is governed by DNA methylation established in the gametes and maintained throughout development. The frequency and extent of epimutations associated with the nine reported imprinting syndromes varies, since it is evident that aberrant pre-implantation maintenance of imprinted differentially methylated regions (DMRs) may affect multiple loci. Using a custom Illumina Goldengate array targeting 27 imprinted-DMRs we profiled allelic methylation in 65 imprinting defect patients. We identify multi-locus hypomethyaltion in numerous BWS, TNDM and PHP-1B patients, and an individual with SRS. Our data reveals a broad range of epimutations exist in certain imprinting syndromes, with the exception of PWS and AS patients that are associated with solitary SNRPN-DMR defects. A mutation analysis identified a 1 bp deletion in the ZFP57 gene in a TNDM patient with methylation defects at multiple maternal DMRs. In addition we observe missense variants in ZFP57, NLRP2, and NLRP7 that are not consistent with maternal effect and aberrant establishment or methylation maintenance, and are likely benign. This work illustrates that further extensive molecular characterization of these rare patients is required to fully understand the mechanism underlying the aetiology of imprint establishment and maintenance.
    Human Mutation 01/2013; · 5.21 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Silver-Russell syndrome (SRS) is a congenital imprinting disorder characterized by intrauterine and postnatal growth restriction and further characteristic features. SRS is genetically heterogenous: 7-10% of patients carry a maternal uniparental disomy of chromosome 7; >38% show a hypomethylation in imprinting control region 1 in 11p15; and a further class of mutations are copy number variations affecting different chromosomes, but mainly 11p15 and 7. The diagnostic work-up should thus aim to detect these three molecular subtypes. Numerous techniques are currently applied in genetic SRS testing, but none of them covers all known (epi)mutations, and they should therefore be used synergistically. However, future next-generation sequencing approaches will allow a comprehensive analysis of all types of alterations in SRS.
    Expert Review of Molecular Diagnostics 06/2012; 12(5):459-71. · 4.09 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Our understanding of Beckwith-Wiedemann syndrome (BWS) has recently been enhanced by advances in its molecular characterization. These advances have further delineated intricate (epi)genetic regulation of the imprinted gene cluster on chromosome 11p15.5 and the role of these genes in normal growth and development. Studies of the molecular changes associated with the BWS phenotype have been instrumental in elucidating critical molecular elements in this imprinted region. This review will provide updated information on the multiple new regulatory elements that have been recently found to contribute to in cis or in trans control of imprinted gene expression in the chromosome 11p15.5 region and the clinical expression of the BWS phenotype. © 2013 Wiley Periodicals, Inc.
    American Journal of Medical Genetics Part C Seminars in Medical Genetics 04/2013; · 4.44 Impact Factor

Full-text (2 Sources)

Available from
May 21, 2014